专题:Drug-Induced Ocular Toxicity

This cluster of papers focuses on the ocular toxicity and retinal disorders associated with medications such as chloroquine, hydroxychloroquine, tamoxifen, and ethambutol. It covers topics such as retinopathy, maculopathy, optic neuropathy, and cardiomyopathy induced by these drugs. The papers also discuss screening guidelines, imaging techniques like multifocal electroretinography and optical coherence tomography (OCT), and the implications for rheumatology care.
最新文献
Systemic Drugs Associated With Maculopathy

article Full Text OpenAlex

A Pediatric Case of Hydroxychloroquine Cardiotoxicity Leading to End-stage Heart Failure

article Full Text OpenAlex

Bilateral Exudative Chorioretinopathy in All-trans Retinoic Acid–Associated Differentiation Syndrome

article Full Text OpenAlex

Retrospective cohort study of ocular adverse reactions to systemic drugs: insights from a multi-country spontaneous reporting database

article Full Text OpenAlex

Exemestane-Associated Bilateral Maculopathy

article Full Text OpenAlex

Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide

letter Full Text OpenAlex

Comment on bilateral optic disc edema as the presenting sign of brain metastasis

article Full Text OpenAlex

Ethyl-loflazepate/etizolam

article Full Text OpenAlex

Comparing and analyzing the differences between SERMs retinochoroidopathy and Macular Telangiectasia Type 2: a new pathogenic hypothesis

preprint Full Text OpenAlex

Pseudotumorcerebri – a rare complication of ATRA based treatment of Acute Promyelocytic Leukaemia

article Full Text OpenAlex

近5年高被引文献
Acute promyelocytic leukemia current treatment algorithms

review Full Text OpenAlex 208 FWCI14.72739651

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge

review Full Text OpenAlex 160 FWCI40.26912571

American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal Toxicity

article Full Text OpenAlex 107 FWCI18.79478996

Arsenic in medicine: past, present and future

review Full Text OpenAlex 97 FWCI11.93770832

Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

article Full Text OpenAlex 90 FWCI16.27846919

Methanol-induced optic neuropathy: a still-present problem

review Full Text OpenAlex 82 FWCI27.56074059

Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial

article Full Text OpenAlex 74 FWCI8.85752949

Hydroxychloroquine and COVID-19: a Rheumatologist’s Take on the Lessons Learned

review Full Text OpenAlex 67 FWCI14.89830912

Natural history of patients with Leber hereditary optic neuropathy—results from the REALITY study

article Full Text OpenAlex 64 FWCI4.87662136

The Royal College of Ophthalmologists recommendations on monitoring for hydroxychloroquine and chloroquine users in the United Kingdom (2020 revision): executive summary

editorial Full Text OpenAlex 63 FWCI11.23103303